2021 Controlled & Modified Drug Release Virtual SummitFebruary 24 - 25, 2021 | Virtual Summit
Join over 160 leading drug delivery, formulation and development experts and learn over 2 YEARS worth of new product development strategies, formulation approaches, delivery technologies and more in just 2 days!
Coupled with the challenges of the COVID-19 pandemic, the drug development model now more than ever is in need of a drastic shakeup. With lengthy and costly approval processes, generic incursion, rising development costs and the challenge of adherence, pharma and biotech need to innovative product development and delivery to improve therapeutic performance.
Now in it’s 7th successful year, the 2021 Controlled & Modified Drug Release Summit will provide you and your team this dose of innovation. Attendees learn directly from industry’s leading experts and hear multiple unique case study sessions and take-home examples to enhance their product pipelines. 2021’s Summit showcases the latest technologies and methods for improving drug release mechanisms, maximizing exposure, and reducing time-to-market. Additionally, this must-attend event will showcase the latest regulatory guidance updates and the implications for the industry..
Are you looking to improve the performance of your drug products? Register to attend today and walk away with game-changing development strategies which could decrease time-to-market and save you millions.
2021 Themes Include:
- Precision medicine & healthcare delivery: making precision medicine a reality via novel technology advancements
- Regulatory guidance for modified release dosage forms
- Advances in ocular delivery
- Micro and nanoparticle delivery
- Parenteral routes of administration
- Topical and transdermal delivery
- Oral peptide commercialization and delivery
- Enhancing patient adherence via drug delivery
- Oral drug formulation and delivery technologies
WANT TO ATTEND CR7 BUT NEED HELP CONVINCING YOUR BOSS?
Let us help by generating you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it to them 280 characters at a time: up to you.
Previous Speakers Included:
Tycho Heimbach, PhD
Director, PK Sciences, PBPK and Biopharmaceutics, Novartis
Rakesh Dixit, PhD
Vice President, R&D, Head Biologics Safety Assessment, AstraZeneca
Mohammad Al-Sayah, PhD
Senior Scientist, Drug Product Development, Genentech Inc.
Eric Munson, PhD
Head, Department of Industrial and Physical Pharmacy, Purdue University
Yingkai Liang, PhD
Senior Scientist, Discovery Pharmaceutical Sciences, Merck & Co.
Jae Yoo, PhD
Chief Technology Officer, Aprecia Pharmaceuticals
Scott Shandler, PhD
Founder and CEO, Longevity Biotech
Vincent Ling, PhD
Senior Director, Advanced Technologies, Drug Product Development, Takeda
Di Bei, PhD
Senior Clinical Pharmacologist, Bristol-Myers Squibb
Victor Hruby, PhD
Regents Professor, Department of Chemistry, University of Arizona
Umar Maharoof, PhD
Associate Director, Dosage Form Development, Medimmune
Xiaoling Li, PhD
Associate Dean and Professor, University of the Pacific
John Lambris, PhD
Dr. Ralph and Sallie Weaver Professor of Research Medicine, University of Pennsylvania
Biplop Mitra, PhD
Principal Research Scientist, Drug Product Development, Celgene Corporation
Daniel Skomski, PhD
Senior Scientist, Merck
Shirlynn Chen, PhD
Distinguished Research Fellow, Boehringer Ingelheim
Subscribe and receive free pharma R & D strategies, podcast episodes, tips and weekly resources directly from Curtis & Coulter to your inbox
2019 Sponsors & Exhibitors
Register before Dec 31st, 2020
Register Before Feb 1st, 2021
Register Feb 15, 2021 Onwards